HOOKIPA PHARMA INC's ticker is HOOK and the CUSIP is 43906K100. A total of 75 filers reported holding HOOKIPA PHARMA INC in Q1 2022. The put-call ratio across all filers is 1.35 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $0 | -100.0% | 161 | -98.5% | 0.00% | – |
| Q1 2022 | $25,000 | 0.0% | 10,861 | -0.3% | 0.00% | – |
| Q4 2021 | $25,000 | -60.9% | 10,890 | 0.0% | 0.00% | – |
| Q3 2021 | $64,000 | -35.4% | 10,890 | +0.6% | 0.00% | – |
| Q2 2021 | $99,000 | -31.2% | 10,823 | +1.1% | 0.00% | – |
| Q1 2021 | $144,000 | +21.0% | 10,700 | 0.0% | 0.00% | – |
| Q4 2020 | $119,000 | +17.8% | 10,700 | 0.0% | 0.00% | – |
| Q3 2020 | $101,000 | -34.0% | 10,700 | -18.9% | 0.00% | – |
| Q2 2020 | $153,000 | +337.1% | 13,200 | +207.0% | 0.00% | – |
| Q1 2020 | $35,000 | -34.0% | 4,300 | 0.0% | 0.00% | – |
| Q4 2019 | $53,000 | +65.6% | 4,300 | 0.0% | 0.00% | – |
| Q3 2019 | $32,000 | -69.2% | 4,300 | -72.1% | 0.00% | – |
| Q2 2019 | $104,000 | – | 15,400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Samsara BioCapital, LLC | 530,245 | $3,569,000 | 2.36% |
| Redmile Group, LLC | 1,891,879 | $12,732,000 | 0.36% |
| Artal Group S.A. | 1,134,616 | $7,636,000 | 0.31% |
| DC Investments Management, LLC | 42,857 | $288,000 | 0.16% |
| Hillhouse Capital Management | 657,540 | $4,425,000 | 0.14% |
| HHLR ADVISORS, LTD. | 285,714 | $1,923,000 | 0.04% |
| Baker Brothers Advisors | 892,857 | $6,009,000 | 0.04% |
| Tower Research Capital LLC (TRC) | 6,011 | $40,000 | 0.00% |
| Artisan Partners Limited Partnership | 126,273 | $850,000 | 0.00% |
| SALEM INVESTMENT COUNSELORS INC | 900 | $6,000 | 0.00% |